# A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults

> **NCT03137017** · PHASE1 · WITHDRAWN · sponsor: **Grünenthal GmbH**

## Conditions studied

- Opioid-Related Disorders
- Pain, Acute
- Pain, Postoperative

## Interventions

- **DRUG:** Norco 5Mg-325Mg Tablet
- **DRUG:** GRT7014 - Abuse Deterrent Tablet

## Key facts

- **NCT ID:** NCT03137017
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-09
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** program discontinued
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03137017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03137017, "A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03137017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*